John Theurer Cancer Center became one of the few sites in the country offering chimeric antigen receptor (CAR) T-cell therapy—a highly promising immunotherapy for certain blood cancers. Dr. Andre Goy highlights this therapy. Andre Goy, MD, is a hematologist/oncologist and chairman and executive director of the John Theurer Cancer Center which has been involved in CAR-T cell therapy research for almost a decade. Dr. Goy, who also serves as chief of the center’s Lymphoma Division and professor of medicine at Georgetown University, is a world-renowned expert on treating cancer with immunotherapies.
What are you looking for? or call our Health Specialists at 1-844-HMH-WELL